1. Home
  2. KALA vs ELVA Comparison

KALA vs ELVA Comparison

Compare KALA & ELVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo KALA BIO Inc.

KALA

KALA BIO Inc.

N/A

Current Price

$0.36

Market Cap

319.6M

Sector

Health Care

ML Signal

N/A

Logo Electrovaya Inc.

ELVA

Electrovaya Inc.

N/A

Current Price

$8.55

Market Cap

359.5M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
KALA
ELVA
Founded
2009
1996
Country
United States
Canada
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
319.6M
359.5M
IPO Year
2017
2021

Fundamental Metrics

Financial Performance
Metric
KALA
ELVA
Price
$0.36
$8.55
Analyst Decision
Buy
Buy
Analyst Count
3
1
Target Price
$31.50
$14.00
AVG Volume (30 Days)
731.1K
435.4K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
41.50
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$33.92
Revenue Next Year
N/A
$56.86
P/E Ratio
N/A
$78.51
Revenue Growth
N/A
N/A
52 Week Low
$0.23
$2.30
52 Week High
$20.58
$11.88

Technical Indicators

Market Signals
Indicator
KALA
ELVA
Relative Strength Index (RSI) 45.33 53.10
Support Level $0.35 $8.11
Resistance Level $0.72 $9.12
Average True Range (ATR) 0.05 0.51
MACD 0.00 0.10
Stochastic Oscillator 70.79 98.68

Price Performance

Historical Comparison
KALA
ELVA

About KALA KALA BIO Inc.

Kala Bio Inc is a biopharmaceutical company. The company is a clinical-stage biopharmaceutical company dedicated to researching, developing, and commercializing therapies for rare and severe eye diseases. KALA'smain product candidate, KPI-012, is a human MSC-S, which contains numerous human-derived biofactors, such as growth factors, protease inhibitors, matrix proteins, and neurotrophic factors that can potentially correct the impaired corneal healing that is an underlying etiology of multiple severe ocular diseases. Its MSC-S platform is for retinal degenerative diseases, such as Retinitis Pigmentosa and Stargardt Disease.

About ELVA Electrovaya Inc.

Electrovaya Inc is a technology-focused lithium-ion battery company engaged in designing, developing and manufacturing battery cells, modules and systems based on its proprietary Infinity Battery Technology, which provides high safety performance, long cycle life and durability. The Company supplies low-voltage and high-voltage battery systems for industrial and transportation markets, including material-handling equipment, robotic vehicles, electric buses and trucks, and energy-storage installations, and its products are suitable for mission-critical applications. it maintains an expanding intellectual-property portfolio, develops next-generation solid-state and hybrid solid-state battery technologies, and sells its products through OEM relationships, dealer networks and direct sales.

Share on Social Networks: